Related Experiment Video
Updated: Jan 21, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Synthetic lethality between BRCA1 deficiency and poly(ADP-ribose) polymerase inhibition is modulated by processing of
Sara Giovannini1,2,3, Marie-Christine Weller2, Simone Repmann2
1Institute of Molecular Life Sciences of the University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Abstract:
Poly(ADP-ribose) polymerases (PARPs) facilitate the repair of DNA single-strand breaks (SSBs). When PARPs are inhibited, unrepaired SSBs colliding with replication forks give rise to cytotoxic double-strand breaks. These are normally rescued by homologous recombination (HR), but, in cells with suboptimal HR, PARP inhibition leads to genomic instability and cell death, a phenomenon currently exploited in the therapy of ovarian cancers in BRCA1/2 mutation carriers. In spite of their promise, resistance to PARP inhibitors (PARPis) has already emerged. In order to identify the possible underlying causes of the resistance, we set out to identify the endogenous source of DNA damage that activates PARPs. We argued that if the toxicity of PARPis is indeed caused by unrepaired SSBs, these breaks must arise spontaneously, because PARPis are used as single agents. We now show that a significant contributor to PARPi toxicity is oxygen metabolism. While BRCA1-depleted or -mutated cells were hypersensitive to the clinically approved PARPi olaparib, its toxicity was significantly attenuated by depletion of OGG1 or MYH DNA glycosylases, as well as by treatment with reactive oxygen species scavengers, growth under hypoxic conditions or chemical OGG1 inhibition. Thus, clinical resistance to PARPi therapy may emerge simply through reduced efficiency of oxidative damage repair.
Insights
PARP inhibitors (PARPis) exploit DNA repair defects. This study reveals that oxygen metabolism contributes to PARPi toxicity, and reduced oxidative damage repair may cause resistance to these cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Therapeutics
- DNA Repair
Background:
- Poly(ADP-ribose) polymerases (PARPs) are crucial for repairing DNA single-strand breaks (SSBs).
- PARP inhibition leads to cell death in cancers with homologous recombination (HR) deficiencies, such as those with BRCA1/2 mutations.
- Emerging resistance to PARP inhibitors (PARPis) necessitates understanding the endogenous DNA damage sources activating PARPs.
Purpose of the Study:
- To identify the endogenous source of DNA damage that activates PARPs, contributing to PARPi toxicity.
- To investigate the role of oxygen metabolism in PARPi-induced DNA damage and cell death.
- To explore mechanisms underlying clinical resistance to PARPis.
Main Methods:
- Assessing the sensitivity of BRCA1-depleted/mutated cells to the PARPi olaparib.
- Evaluating the effect of OGG1 or MYH DNA glycosylase depletion on PARPi toxicity.
- Testing the impact of reactive oxygen species (ROS) scavengers, hypoxia, and chemical OGG1 inhibition on PARPi efficacy.
Main Results:
- BRCA1-deficient cells exhibited hypersensitivity to olaparib.
- Depletion of OGG1 or MYH, ROS scavenging, hypoxic conditions, or chemical OGG1 inhibition significantly attenuated olaparib toxicity.
- These findings indicate that oxidative DNA damage contributes significantly to PARPi toxicity.
Conclusions:
- Oxygen metabolism is a significant contributor to PARPi toxicity.
- Reduced efficiency in repairing oxidative DNA damage may be a mechanism for clinical resistance to PARPi therapy.
- Targeting oxidative damage repair could offer strategies to overcome PARPi resistance.
More Related Videos
Related Concept Videos
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
Overview of DNA Repair
Chemically...
RNA Polymerase II Accessory Proteins
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
DNA Damage Can Stall the Cell Cycle

